EXEL (NASDAQ: EXEL) executive files Form 144 to sell compensation shares
Rhea-AI Filing Summary
EXEL filing a Form 144 that lists proposed sales of common stock by an executive/affiliate. The excerpt shows multiple lots tied to restricted stock vesting, performance stock units, and an employee stock purchase plan with dated entries ranging from 04/30/2024 to 05/15/2025.
The filing lists several share lots (e.g., 6,223 shares, 6,246 shares, 7,794 shares) associated with issuer-issued compensation and proposed resale; proceeds treatment and aggregate offer total are not stated in the provided excerpt.
Positive
- None.
Negative
- None.
Insights
Form 144 lists proposed executive-affiliate resales tied to compensation awards.
The excerpt records multiple lots of Common stock linked to restricted stock vesting, performance stock units, and an employee stock purchase plan, with dates from 04/30/2024 to 05/15/2025. The presence of issuer-originated awards suggests these are planned dispositions of compensation-related shares.
Filing does not state aggregate proceeds or whether sales are open-market or block trades; cash-flow treatment is not specified in the provided excerpt. Subsequent filings or a complete Form 144 would show broker/dealer and aggregate amount details.
Key Figures
Key Terms
Form 144 regulatory
Restricted stock vesting financial
Performance Stock Units financial
Employee Stock Purchase Plan financial
AI-generated analysis. How Rhea-AI works. Not financial advice.